PMAH — Plasmatech Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2004 | 2005 | 2006 | 2007 | 2008 | 2009E | 2010E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
PLASMAtech Inc. supplies surface treatment services and equipment based on low pressure microwave plasma and parylene coating technology. The Company provides plasma-enhanced chemical vapor deposition (PECVD) coating and surface treatment applications. It also offers plasma and parylene equipment, as well as contract services and process research and development in its good manufacturing practices (GMP)-compliant facility. Its contract services include cleaning, surface treatment and coatings. Plasma cleaning is used in cleaning ceramic components used in medical devices, removal of organic contamination on metals or polymers, cleaning medical implantable prior to coating and removing carbon residual after laser drilling. Surface treatment is used in treatment of balloon catheter components prior to coating or bonding, modification/functionalization of culture components for cell attachment, treatment/cleaning of ophthalmic lenses prior to coating and treatment of Webs and films.
Directors
- Marvin Williams CEO (71)
- Christopher Brough DRC (68)
- John McLane DRC
- David Saltrelli DRC (64)
- Steve Malizia IND
- Last Annual
- December 31st, 2008
- Last Interim
- September 30th, 2009
- Incorporated
- January 18th, 1996
- Public Since
- July 13th, 2007
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 70,920,000

- Address
- 4905 34th Street South, Suite 440, ST PETERSBURG, 33711
- Web
- https://www.plasmatechnology.com/
- Phone
- +1 7273079528
- Auditors
- Moore & Assoc.
Similar to PMAH
3DX Industries
Pink Sheets on Nasdaq
420 Property Management
Pink Sheets on Nasdaq
Abb
Pink Sheets on Nasdaq
Abound Energy
Pink Sheets on Nasdaq
Allego NV
Pink Sheets on Nasdaq
FAQ
As of Today at 22:40 UTC, shares in Plasmatech are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Plasmatech last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Plasmatech share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out morePlasmatech does not currently pay a dividend.
Plasmatech does not currently pay a dividend.
Plasmatech does not currently pay a dividend.
To buy shares in Plasmatech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Plasmatech had a market capitalisation of .
Here are the trading details for Plasmatech:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PMAH
Based on an overall assessment of its quality, value and momentum Plasmatech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Plasmatech. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Plasmatech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Plasmatech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Plasmatech's management team is headed by:
- Marvin Williams - CEO
- Christopher Brough - DRC
- John McLane - DRC
- David Saltrelli - DRC
- Steve Malizia - IND